Pharmanutra S.p.A. (BIT:PHN)

Italy flag Italy · Delayed Price · Currency is EUR
66.70
+0.60 (0.91%)
At close: Mar 5, 2026
20.18%
Market Cap 640.54M
Revenue (ttm) 127.15M
Net Income (ttm) 17.45M
Shares Out 9.60M
EPS (ttm) 1.82
PE Ratio 36.68
Forward PE 28.27
Dividend 1.00 (1.51%)
Ex-Dividend Date May 5, 2025
Volume 18,665
Average Volume 18,156
Open 66.00
Previous Close 66.10
Day's Range 65.00 - 67.60
52-Week Range 38.75 - 68.10
Beta 0.30
RSI 60.43
Earnings Date Mar 13, 2026

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and softwar... [Read more]

Sector Healthcare
Founded 2003
Employees 136
Stock Exchange Borsa Italiana
Ticker Symbol PHN
Full Company Profile

Financial Performance

In 2024, Pharmanutra's revenue was 116.15 million, an increase of 15.33% compared to the previous year's 100.71 million. Earnings were 16.61 million, an increase of 29.43%.

Financial Statements

News

There is no news available yet.